ClinicalTrials.gg
Status unknownNCT03262844Updated Sep 27, 2018

Efficacy and Safety of Nerve Root Axial Decompression Surgery in The Treatment of Tethered Cord Syndrome

An interventional study of Conservative treatment and Capsule surgery in Tethered Cord Syndrome, sponsored by Shanghai Changzheng Hospital. Status unknown at 1 site in China. Open to participants aged 14 Years to 20 Years. Per ClinicalTrials.gov, last updated 2018-09-27.

Sponsored by Shanghai Changzheng Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
14 Years to 20 Years
Sex
All
01

Study summary

Background: Tethered cord syndrome (TCS) is a progressive clinical condition including a series of neurological dysfunctions and deformities attributable to abnormally increased tension on the spinal cord, which is lacking effective treatment to relieve the symptoms and prevent progression. Dr. Shi recently proposed a new technique as nerve root axial decompression surgery, which is also called capsule surgery, to treat patients with TCS. Yet, the effectiveness and safety should be further studied.

Purpose: The aim of this study is to compare the effectiveness and safety of clinical outcomes between capsule surgery and conservative treatment in patients with TCS. A study hypothesis is that outcomes will be improved after capsule surgery.

Methods: This study is a randomized clinical trial with a two-factor (2x7) research design. The TCS patients will be randomly assigned in one of the two treatment groups: capsule surgery and conservative treatment. Seven outcome measures will be collected pre-operative for baseline, and then at1, 12, 24, 48, and 96 weeks post-operative follow-up visits, including: International Consultation on Incontinence Modular Questionnaire Short Version (ICI-Q-SF), Rintala Score, a new developed Chinese version of questionnaire, Oswestry disability index (ODI), SF-12, foot function index (FFI) and Pirani score. Urodynamic testing, bladder ultrasonography, electromyogram, muscle strength and sensation of lower limbs will be obtained before and post treatment, to determine the patient's function of lower limbs. The investigator performing the outcome measures will be blinded to group assignment, and therefore will not participate in treatment. After randomization, the conservative group will be followed up in the outpatient clinic. The capsule surgery group will receive the nerve root axial decompression surgery (capsule surgery).

Data Analysis: Two 2x7 MANOVAs with repeated measures will be used to examine the differences in the seven measures between groups and at the five different time frames with the α level set at 0.05. Non-parametric tests (Mann-Whitney U tests) will be used to compare the differences in the urodynamics and muscle strength data over time and between groups.

Read the detailed description

Background: Tethered cord syndrome (TCS) is a progressive clinical condition including a series of neurological dysfunctions and deformities attributable to abnormally increased tension on the spinal cord. The standard surgical treatment is untethering the spinal cord and correction of the related deformity. Although reported results are encouraging, it continues to pose challenges on management of TCS patients. Symptomatic re-tethering seems to be an inevitable result, which occurs in 20%-50% patients after untethering. Recently, filum dissection was found no good to improve urinary symptoms compared to conservative treatment in teenagers as reported in an RCT study. Also, it remained controversy when to perform the surgery and how to evaluate the benefits of surgery or conservative treatment. Dr. Shi recently proposed a new technique as nerve root axial decompression surgery, which is also called capsule surgery, to treat patients with TCS. Yet, the effectiveness and safety should be further studied.

Purpose: The aim of this study is to compare the effectiveness and safety of clinical outcomes between capsule surgery and conservative treatment in patients with TCS. A study hypothesis is that outcomes will be improved after capsule surgery.

Methods: This study is a randomized clinical trial with a two-factor (2x7) research design. The TCS patients will be randomly assigned in one of the two treatment groups: capsule surgery and conservative treatment. Seven outcome measures will be collected pre-operative for baseline, and then at1, 12, 24, 48, and 96 weeks post-operative follow-up visits, including: (1) International Consultation on Incontinence Modular Questionnaire Short Version (ICI-Q-SF) to assess the urinary functions, (2) Rintala Score for bowel function, (3) a new developed Chinese version of questionnaire to assess the quality of life in patients and parents due to bladder dysfunction. (4) Oswestry disability index (ODI) to assess the function of back and lower limbs, (5)SF-12 for whole quality of life, (6) Pirani score to assess clubfoot deformity, and (7) foot function index to assess the impacts on quality of life due to clubfoot. Urodynamics, bladder ultrasonography, muscle strength and sensation of lower limbs will be obtained before and post treatment, to determine the patient's function of lower limbs. The investigator performing the outcome measures will be blinded to group assignment, and therefore will not participate in treatment. After randomization, the conservative group will be followed up in the outpatient clinic. The capsule surgery group will receive the nerve root axial decompression surgery.

Data Analysis: Two 2x7 MANOVAs with repeated measures will be used to examine the differences in the four measures between groups and at the five different time frames with the α level set at 0.05. Non-parametric tests (Mann-Whitney U tests) will be used to compare the differences in the urodynamics and muscle strength data over time and between groups.

02

Conditions studied

  • Tethered Cord Syndrome

Browse trials for

03

In context

Neural Tube Defects

47 studies on the registry are indexed under Neural Tube Defects; 9 are open to participants now.

This study's planned enrollment of 36 is below the median of 47 across 26 interventional studies indexed under Neural Tube Defects.

Browse Neural Tube Defects studies →

Lead sponsor

Shanghai Changzheng Hospital is the lead sponsor of 128 studies on the registry; 60 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. patients aged 14-20 years, without gender limitation, are willing to sign ;
  2. patients diagnosed with tethered cord syndrome (TCS);
  3. patients accepted untethering surgery or resection of intra-lipomas or myelomeningocele after birth;
  4. patients present with the recent occurrence of bladder or bowel dysfunction, with progressive deterioration, may be accompanied by motor deficits of lower extremity;
  5. urodynamic examination suggests neurogenic injury;
  6. the current conventional treatment is difficult to achieve satisfactory clinical outcomes.

Exclusion criteria

Exclusion Criteria:

  1. bladder or ureter obstruction;
  2. other types of neurogenic bladder dysfunction (spinal cord injury, cerebral palsy, other brain injuries);
  3. anorectal malformations;
  4. poor health condition, unable to tolerate surgery;
  5. patients (or their guardians) cannot give full for cognitive dysfunction;
  6. patients who have participated in other clinical trials in the past 1 month.
  7. patients with active (including HBeAg) or serological markers (HBsAg or / and HBeAg or / and HBcAb), , tuberculosis, cytomegalovirus infection, severe fungal infection or infection;
  8. patients with active peptic ulcers within 3 months before randomization.
  9. patients with malignant neoplasms
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Hepatitis B tests

Hepatitis B is a virus that infects the liver. These are separate tests: HBsAg positive usually means a current infection (a recent vaccination can briefly cause it too); total anti-HBc (HBcAb) positive means an infection now or in the past; HBV DNA measures how much virus is in the blood.

Some studies accept a past infection if HBV DNA is undetectable, sometimes with antiviral medicine during the study. Check what this study allows.

Hepatitis C tests

Hepatitis C is a virus that infects the liver. An HCV antibody test can stay positive after an infection has cleared (and is occasionally positive without one); an HCV RNA test shows whether the virus is there now.

After treatment, hepatitis C counts as cured when HCV RNA is still undetectable 12 weeks or more after the treatment ended. Studies often accept people cured this way.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Placebo comparator
    Conservative treatment

    Conservative physiotherapy, intermittent catheterization, or drug treatment for bladder or bowel dysfunction

    Behavioral: Conservative treatment

  • Experimental
    Capsule surgery

    Nerve root axial decompression surgery (Capsule surgery)

    Procedure: Capsule surgery

Interventions

  • BehavioralConservative treatment

    The conservative treatment group will be given diet and nursing guidance, then the drug treatment or physiotherapy will be given according to the conditions of patients. Patients with bladder dysfunction will be guided to perform routine intermittent catheterization with help of their parents.

  • ProcedureCapsule surgery

    In the multiple segments of the spine, articular facet joint and intervertebral disc will be resected to achieve the effect of decompression. Specific surgical segments, osteotomy range, decompression degree of each patient needs to be designed individually.

06

What researchers measure

Primary outcomes

  1. Changes of patient-reported scores assessing bladder function

    International Consultation on Incontinence Modular Questionnaire Short Version (ICI-Q-SF) is used to assess urinary function and the impacts on patient's quality of life due to urinary problems.

    Time frame: At 1 week pre- and 1, 12, 24, 48, and 96 weeks post-operative follow-up visits.

Secondary outcomes

  1. Changes of patient-reported scores assessing bowel function

    Rintala Score is applied to assess bowel function and its effects on patients' quality of life.

    Time frame: At 1 week pre- and 1, 12, 24, 48, and 96 weeks post-operative follow-up visits.

  2. Changes of patient-reported quality of life due to bladder dysfuction

    A new developed Chinese version of questionnaire is used to assess the quality of life in patients and parents due to bladder dysfunction.

    Time frame: At 1 week pre- and 1, 12, 24, 48, and 96 weeks post-operative follow-up visits.

  3. Bladder function

    Urodynamic testing is performed to determine the bladder function, including bladder pressure, bladder capacity, residual volume, and compliance of bladder.

    Time frame: At 1 week pre- and 1, 12, 48, and 96 weeks post-operative follow-up visits.

  4. Muscle power

    Muscle power is tested by manual assessment, which is classified into 6 levels.

    Time frame: At 1 week pre- and 1, 12, 24, 48, and 96 weeks post-operative follow-up visits.

  5. Improvment of clubfoot deformity

    Pirani questionnaire is applied to assess the severity of clubfoot deformity by the examiner.

    Time frame: At 1 week pre- and 1, 12, 24, 48, and 96 weeks post-operative follow-up visits.

  6. Changes of patient-reported scores assessing foot deformity

    Foot function index is applied to assess the impacts on patients' quality of life due to foot deformity

    Time frame: At 1 week pre- and 1, 12, 24, 48, and 96 weeks post-operative follow-up visits.

  7. Changes of patient-reported scores assessing function of back and lower limbs

    Oswestry disability index (ODI) is applied to assess the function of back and lower limbs.

    Time frame: At 1 week pre- and 1, 12, 24, 48, and 96 weeks post-operative follow-up visits.

  8. Changes of patient-reported quality of life

    SF-12 is applied to assess the impacts on quality of life due to tethered cord syndrome.

    Time frame: At 1 week pre- and 1, 12, 24, 48, and 96 weeks post-operative follow-up visits.

07

Study locations

1 of 1 sites recruiting
  • Shanghai Changzheng Hospital
    Shanghai, Shanghai 200001, China
    Recruiting
08

References and documents

Publications

  • Steinbok P, MacNeily AE, Hengel AR, Afshar K, Landgraf JM, Hader W, Pugh J. Filum Section for Urinary Incontinence in Children with Occult Tethered Cord Syndrome: A Randomized, Controlled Pilot Study. J Urol. 2016 Apr;195(4 Pt 2):1183-8. doi: 10.1016/j.juro.2015.09.082. Epub 2016 Feb 28. PubMed 26926544 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2017 (actual). Primary completion is estimated for Apr 2019, 22 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 6, 2017
First posted
Aug 25, 2017
StartActual
Jun 16, 2017
Primary completionEst.
Apr 2019
CompletionEst.
Apr 2020
Last update
Sep 27, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 27, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03262844
Responsible party
Jiangang Shi (Chief of No.2 department of spinal surgery, Shanghai Changzheng Hospital) — Principal investigator
First posted
Aug 25, 2017
Start date
Jun 16, 2017
Primary completion
Apr 2019 (estimated)
Completion
Apr 2020 (estimated)
Last update
Sep 27, 2018

Study contacts

Ximing Xu, MD
Contact
xi_mingxu@hotmail.com
+8618801784094
Jiangang Shi, MD
study chair · Shanghai Changzheng Hospital, Second Military Medical University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion